These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1605021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Partial laryngectomy after irradiation failure.
    Yiotakis J, Stavroulaki P, Nikolopoulos T, Manolopoulos L, Kandiloros D, Ferekidis E, Adamopoulos G.
    Otolaryngol Head Neck Surg; 2003 Feb; 128(2):200-9. PubMed ID: 12601315
    [Abstract] [Full Text] [Related]

  • 4. [Results of treatment for laryngeal carcinoma in Würzburg].
    Bohndorf W, Höcker G.
    Strahlentherapie; 1976 Feb; 151(2):132-43. PubMed ID: 1258083
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
    Jones AS, Fish B, Fenton JE, Husband DJ.
    Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
    [Abstract] [Full Text] [Related]

  • 7. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K, Someya M, Hori M, Nakata K, Takagi M, Hareyama M.
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quality control in planning and technique of radiotherapy with cobalt-60 for T1 glottic cancer increase local control and organ preservation.
    Cortes-Arroyo H, Rodríguez-Cuevas S, Labastida S.
    Am J Surg; 1997 Nov; 174(5):477-80. PubMed ID: 9374218
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
    Inoue T, Inoue T, Teshima T, Murayama S, Yamazaki H, Nose T, Tanaka E.
    Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
    [Abstract] [Full Text] [Related]

  • 18. Radiotherapy in early glottic carcinoma.
    Kanonier G, Fritsch E, Rainer T, Thumfart WF.
    Ann Otol Rhinol Laryngol; 1996 Oct; 105(10):759-63. PubMed ID: 8865769
    [Abstract] [Full Text] [Related]

  • 19. Surgical management of irradiation failures in T1-T2 squamous cell carcinoma of the glottic larynx.
    Virtaniemi JA, Hirvikoski PP, Kumpulainen EJ, Johansson RT, Kosma VM.
    Anticancer Res; 2001 Oct; 21(6A):4185-8. PubMed ID: 11911316
    [Abstract] [Full Text] [Related]

  • 20. Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failure.
    Ballo MT, Garden AS, El-Naggar AK, Gillenwater AM, Morrison WH, Goepfert H, Ang KK.
    Laryngoscope; 1998 May; 108(5):760-3. PubMed ID: 9591559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.